¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
4/30 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2022-04-29
Á¶È¸¼ö
198


 

¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. 
 

À̹øÁÖ¿¡ Á¦°¡ ÁغñÇÑ ³í¹®ÀÇ Á¦¸ñÀº 

"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity" À̸ç 

¿ÃÇØ 2¿ù¿¡ Immunity¿¡ ÃâÆÇµÈ ³í¹®ÀÔ´Ï´Ù. 

cDC1°ú cDC2ÀÇ ¿ªÇÒÀº ÃÖ±Ù ¸¹ÀÌ ¾Ë·ÁÁö°Ô µÇ¾ú°í ƯÈ÷ cDC1Àº cross-presentation ¿ªÇÒÀ» Àß ¼öÇàÇÏ´Â °ÍÀ¸·Î Á¤¸®°¡ µÇ¾úÁö¸¸,  ÀÌÀü¿¡µµ Immunity¿¡  Virus infection°ú °°Àº ƯÁ¤ °¨¿° »óȲ¿¡¼­ cDC2°¡ cDC1°ú °°Àº ¿ªÇÒÀ» ¼öÇàÇÒ ¼ö ÀÖÀ½ÀÌ º¸°í µÈ ¹Ù°¡ ÀÖ½À´Ï´Ù. 

À̹ø ³í¹®¿¡¼­´Â Type 1 IFN ¿¡ ÀÇÇؼ­ cDC2°¡ CD8+ T cellÀ» activation ½ÃÅ°´Â »óÅ·ΠÀ¯µµµÇ´Â Á¡À» ¹àÈù ³í¹®ÀÔ´Ï´Ù. 
 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù. 

³í¹® ¸µÅ© : https://doi.org/10.1016/j.immuni.2021.10.020
 
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
5/7 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ³ª·¡ÀÔ´Ï´Ù. À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº ¿ÃÇØ Cell reports¿¡ °ÔÀçµÈ "Interferon-g promotes monocyte-mediated lung injury during influenza infection"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î, ÃÖ±Ùµé¾î influenza A virus (IAV) °¨¿°»óȲ¿¡¼­ IFN-gÀÇ pathogenicÇÑ functionÀÌ ¹àÇôÁö°í ÀÖ´Â °¡¿îµ¥, ÀÌ..
ÀÌÀü±Û
4/30 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä.À̹ø ÁÖ Åä¿äÀÏ ¼¼¹Ì³ª ¹ßÇ¥ÀÚ ÀÌÁ¤Ã¶ÀÔ´Ï´Ù. Á¦°¡ À̹ø ÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº2021³â5¿ùPNAS¿¡ ÃâÆǵÈ'Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation'ÀÔ´Ï´Ù. ÇöÀç Á¦°¡ ½ÇÇè¿¡ ÀÌ¿ëÇÏ°í ÀÖ´Âresistant starch´Âlarge intestine¿¡¼­ Àå³» ¸¶ÀÌÅ©·Î¹ÙÀÌ..